GSC
IDXX icon

Grey Street Capital’s Idexx Laboratories IDXX Stock Holding History

Grey Street Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$298K Buy
+551
New +$301K 0.04% 394

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grey Street Capital's IDXX Position: Q1 2024 in Review

Grey Street Capital opened a new position in Idexx Laboratories (IDXX) in Q1 2024: 551 shares worth $298K. The stake represents 0.04% of the portfolio and ranks #394 among its holdings.

1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Grey Street Capital held 551 shares of Idexx Laboratories worth $298K as of Q1 2024.
  • Idexx Laboratories was a new Grey Street Capital position in Q1 2024.
  • Idexx Laboratories made up 0.04% of Grey Street Capital's portfolio in Q1 2024, its #394 holding.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.